Avalon Advanced Materials Inc. (TSX: AVL) (OTCQB: AVLNF) ("Avalon" or the "Company") is pleased to announce the commissioning of a new Preliminary Economic Assessment ("PEA") for its Nechalacho Rare ...
PMI’s SynCardia STAH is FDA/Health Canada approved and clinically validated. However, its revenues remain modest. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback